37063472 33469205 32870977 36111661 35096276 32511544 35257398 34648533 32511485 34039898 32648891 30086139 35057647 34218667 31876979 - Search Results

Year	Number of Results
2018	1
2019	1
2020	4
2021	6
2022	5
2023	0

1

Randomization, design and analysis for interdependency in aging research: no person or mouse is an island.

Chusyd DE, Austad SN, Dickinson SL, Ejima K, Gadbury GL, Golzarri-Arroyo L, Holden RJ, Jamshidi-Naeini Y, Landsittel D, Mehta T, Oakes JM, Owora AH, Pavela G, Rojo J, Sandel MW, Smith DL Jr, Vorland CJ, Xun P, Zoh R, Allison DB. Chusyd DE, et al. Nat Aging. 2022 Dec;2(12):1101-1111. doi: 10.1038/s43587-022-00333-6. Epub 2022 Dec 22. Nat Aging. 2022. PMID: 37063472 Free PMC article.

2

Looking beyond COVID-19 vaccine phase 3 trials.

Kim JH, Marks F, Clemens JD. Kim JH, et al. Nat Med. 2021 Feb;27(2):205-211. doi: 10.1038/s41591-021-01230-y. Epub 2021 Jan 19. Nat Med. 2021. PMID: 33469205 Review.

3

Potential Biases Arising From Epidemic Dynamics in Observational Seroprotection Studies.

Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Kahn R, et al. Am J Epidemiol. 2021 Feb 1;190(2):328-335. doi: 10.1093/aje/kwaa188. Am J Epidemiol. 2021. PMID: 32870977 Free PMC article.

4

Vaccine clinical trials in low- and middle-income countries: a brief review of standard, newer and proposed approaches.

Deen J, Clemens JD. Deen J, et al. Expert Rev Vaccines. 2022 Nov;21(11):1595-1602. doi: 10.1080/14760584.2022.2126357. Epub 2022 Sep 21. Expert Rev Vaccines. 2022. PMID: 36111661 Review.

5

Quantifying Efficiency Gains of Innovative Designs of Two-Arm Vaccine Trials for COVID-19 Using an Epidemic Simulation Model.

Johnson R, Jackson C, Presanis A, Villar SS, De Angelis D. Johnson R, et al. Stat Biopharm Res. 2022 Jan 2;14(1):33-41. doi: 10.1080/19466315.2021.1939774. Epub 2021 Jul 30. Stat Biopharm Res. 2022. PMID: 35096276 Free PMC article.

6

Statistical Properties of Stepped Wedge Cluster-Randomized Trials in Infectious Disease Outbreaks.

Kennedy-Shaffer L, Lipsitch M. Kennedy-Shaffer L, et al. medRxiv. 2020 May 6:2020.05.01.20087429. doi: 10.1101/2020.05.01.20087429. Preprint. medRxiv. 2020. PMID: 32511544 Free PMC article. Updated.

7

The required size of cluster randomized trials of nonpharmaceutical interventions in epidemic settings.

Sheen JK, Haushofer J, Metcalf CJE, Kennedy-Shaffer L. Sheen JK, et al. Stat Med. 2022 Jun 15;41(13):2466-2482. doi: 10.1002/sim.9365. Epub 2022 Mar 7. Stat Med. 2022. PMID: 35257398 Free PMC article.

8

Intracluster correlation coefficients in a large cluster randomized vaccine trial in schools: Transmission and impact of shared characteristics.

Whelan J, Marshall H, Sullivan TR. Whelan J, et al. PLoS One. 2021 Oct 14;16(10):e0254330. doi: 10.1371/journal.pone.0254330. eCollection 2021. PLoS One. 2021. PMID: 34648533 Free PMC article. Clinical Trial.

9

Potential biases arising from epidemic dynamics in observational seroprotection studies.

Kahn R, Kennedy-Shaffer L, Grad YH, Robins JM, Lipsitch M. Kahn R, et al. medRxiv. 2020 May 6:2020.05.02.20088765. doi: 10.1101/2020.05.02.20088765. Preprint. medRxiv. 2020. PMID: 32511485 Free PMC article. Updated.

10

Leveraging Pathogen Sequence and Contact Tracing Data to Enhance Vaccine Trials in Emerging Epidemics.

Kahn R, Wang R, Leavitt SV, Hanage WP, Lipsitch M. Kahn R, et al. Epidemiology. 2021 Sep 1;32(5):698-704. doi: 10.1097/EDE.0000000000001367. Epidemiology. 2021. PMID: 34039898 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

15 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year